PRUNE2 inhibits progression of colorectal cancer<em> in vitro</em> and <em>in vivo</em>

Li,Ting; Huang,Silin; Yan,Wei; Zhang,Yu; Guo,Qiang

doi:10.3892/etm.2021.11092

PRUNE2 inhibits progression of colorectal cancer in vitro and in vivo

Authors:
- Ting Li
- Silin Huang
- Wei Yan
- Yu Zhang
- Qiang Guo
View Affiliations

Affiliations: Faculty of Environmental Science and Engineering, Kunming University of Science and Technology, Kunming, Yunnan 650500, P.R. China, Medical School, Kunming University of Science and Technology, Kunming, Yunnan 650500, P.R. China, Department of Gastroenterology, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, P.R. China
Published online on: December 27, 2021 https://doi.org/10.3892/etm.2021.11092
Article Number: 169
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Prune homolog 2 with BCH domain (PRUNE2) is associated with prostate cancer, neuroblastoma, glioblastoma and melanoma; however, the function of PRUNE2 in colorectal cancer (CRC) remains unknown. The present study aimed to evaluate the effects of PRUNE2 on the development of CRC. The biological function of PRUNE2 in CRC cell lines was investigated by using Cell Counting Kit‑8, colony formation, flow cytometry and Transwell assay. Additionally, a mouse model was established to investigate the effect of PRUNE2 on metastasis of CRC cells. The expression levels of PRUNE2 were lower in CRC compared with adjacent normal tissue and this expression pattern was associated with poor relapse‑free survival probability. PRUNE2 overexpression significantly decreased cell proliferation and invasion, increased cell apoptosis and arrested the cell cycle. Consistently, it increased the protein expression levels of pro‑apoptosis genes and decreased the expression of antiapoptotic proteins. PRUNE2 knockdown had the opposite effects. Furthermore, PRUNE2 overexpression decreased the tumorigenicity of CRC cells. In conclusion, PRUNE2 decreased cell survival, proliferation, invasion and tumorigenicity and promoted apoptosis, suggesting that PRUNE2 may function as a tumor‑suppressive gene in CRC.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
2	Gu MJ, Huang QC, Bao CZ, Li YJ, Li XQ, Ye D, Ye ZH, Chen K and Wang JB: Attributable causes of colorectal cancer in China. BMC Cancer. 18(38)2018.PubMed/NCBI View Article : Google Scholar
3	Cheng L, Eng C, Nieman LZ, Kapadia AS and Du XL: Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol. 34:573–580. 2011.PubMed/NCBI View Article : Google Scholar
4	Vinson KE, George DC, Fender AW, Bertrand FE and Sigounas G: The notch pathway in colorectal cancer. Int J Cancer. 138:1835–1842. 2016.PubMed/NCBI View Article : Google Scholar
5	Geissler K and Zach O: Pathways involved in Drosophila and human cancer development: The notch, hedgehog, wingless, runt, and trithorax pathway. Ann Hematol. 91:645–669. 2012.PubMed/NCBI View Article : Google Scholar
6	Machida T, Fujita T, Ooo ML, Ohira M, Isogai E, Mihara M, Hirato J, Tomotsune D, Hirata T, Fujimori M, et al: Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas. Oncogene. 25:1931–1942. 2006.PubMed/NCBI View Article : Google Scholar
7	Pan CQ and Low BC: Functional plasticity of the BNIP-2 and Cdc42GAP Homology (BCH) domain in cell signaling and cell dynamics. FEBS Lett. 586:2674–2691. 2012.PubMed/NCBI View Article : Google Scholar
8	Tatsumi Y, Takano R, Islam MS, Yokochi T, Itami M, Nakamura Y and Nakagawara A: BMCC1, which is an interacting partner of BCL2, attenuates AKT activity, accompanied by apoptosis. Cell Death Dis. 6(e1607)2015.PubMed/NCBI View Article : Google Scholar
9	Soh UJ and Low BC: BNIP2 extra long inhibits RhoA and cellular transformation by Lbc RhoGEF via its BCH domain. J Cell Sci. 121:1739–1749. 2008.PubMed/NCBI View Article : Google Scholar
10	Zhao LR, Tian W, Wang GW, Chen KX and Yang JL: The prognostic role of PRUNE2 in leiomyosarcoma. Chin J Cancer. 32:648–652. 2013.PubMed/NCBI View Article : Google Scholar
11	Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, Hunt KK, Pollock RE, Hood L, Shmulevich I and Zhang W: Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci USA. 104:3414–3419. 2007.PubMed/NCBI View Article : Google Scholar
12	Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 487:330–337. 2012.PubMed/NCBI View Article : Google Scholar
13	Vaidyanathan S, Cato K, Tang L, Pavey S, Haass NK, Gabrielli BG and Duijf PH: In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis. Oncogene. 35:5446–5455. 2016.PubMed/NCBI View Article : Google Scholar
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
15	Kazemi T, Younesi V, Jadidi-Niaragh F and Yousefi M: Immunotherapeutic approaches for cancer therapy: An updated review. Artif Cells Nanomed Biotechnol. 44:769–779. 2016.PubMed/NCBI View Article : Google Scholar
16	Salameh A, Lee A, Cardó-Vila M, Nunes DN, Efstathiou E, Staquicini FI, Dobroff AS, Marchiò S, Navone NM, Hosoya H, et al: PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci USA. 112:8403–8408. 2015.PubMed/NCBI View Article : Google Scholar
17	Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH, Saykin AJ, Orro A, Lupoli S, Salvi E, et al: Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One. 4(e6501)2009.PubMed/NCBI View Article : Google Scholar
18	Iwama E, Tsuchimoto D, Iyama T, Sakumi K, Nakagawara A, Takayama K, Nakanishi Y and Nakabeppu Y: Cancer-related PRUNE2 protein is associated with nucleotides and is highly expressed in mature nerve tissues. J Mol Neurosci. 44:103–114. 2011.PubMed/NCBI View Article : Google Scholar
19	Harris JL, Richards RS, Chow CW, Lee S, Kim M, Buck M, Teng L, Clarke R, Gardiner RA and Lavin MF: BMCC1 is an AP-2 associated endosomal protein in prostate cancer cells. PLoS One. 8(e73880)2013.PubMed/NCBI View Article : Google Scholar
20	Quintanilha JCF, Wang J, Sibley AB, Xu W, Espin-Garcia O, Jiang C, Etheridge AS, Ratain MJ, Lenz HJ, Bertagnolli M, et al: Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens. Int J Cancer. 150:279–289. 2022.PubMed/NCBI View Article : Google Scholar
21	Yang JL, Cogdell D, Eddy J, Trent J, Price N and Zhang W: Expression of PRUNE2 mRNA and its positive correlation with non-coding RNA PCA3 in leiomyosarcoma. Zhonghua Zhong Liu Za Zhi. 34:497–500. 2012.PubMed/NCBI View Article : Google Scholar : (In Chinese).
22	Islam MR, Takano R, Yokochi T, Akter J, Nakamura Y, Nakagawara A and Tatsumi Y: Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells. BMC Cancer. 19(542)2019.PubMed/NCBI View Article : Google Scholar
23	Islam MS, Tatsumi Y, Takano R, Yokochi T, Akter J, Ozaki T, Nakamura Y, Ohira M and Nakagawara A: Transcriptional regulation of BMCC1 mediated by E2F1 in neuroblastoma cells. Biochem Biophys Res Commun. 478:81–86. 2016.PubMed/NCBI View Article : Google Scholar
24	Clarke RA, Zhao Z, Guo AY, Roper K, Teng L, Fang ZM, Samaratunga H, Lavin MF and Gardiner RA: New genomic structure for prostate cancer specific gene PCA3 within BMCC1: Implications for prostate cancer detection and progression. PLoS One. 4(e4995)2009.PubMed/NCBI View Article : Google Scholar
25	Su SC, Yeh CM, Lin CW, Hsieh YH, Chuang CY, Tang CH, Lee YC and Yang SF: A novel melatonin-regulated lncRNA suppresses TPA-induced oral cancer cell motility through replenishing PRUNE2 expression. J Pineal Res. 71(e12760)2021.PubMed/NCBI View Article : Google Scholar
26	Bozgeyik E, Kocahan S, Temiz E and Bagis H: miR-19a and miR-421 target PCA3 long non-coding RNA and restore PRUNE2 tumor suppressor activity in prostate cancer. Mol Biol Rep: Nov 27, 2021 (Epub ahead of print). doi: 10.1007/s11033-021-06996-5.
27	Masuda M, Hirakawa N, Nakashima T, Kuratomi Y and Komiyama S: Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer. 78:390–395. 1996.PubMed/NCBI View Article : Google Scholar
28	Bayat Z, Ghaemi Z, Behmanesh M and Soltani BM: Hsa-miR-186-5p regulates TGFβ signaling pathway through expression suppression of SMAD6 and SMAD7 genes in colorectal cancer. Biol Chem. 402:469–480. 2021.PubMed/NCBI View Article : Google Scholar